Home
About
Overview
Sharing Data
ORCID
Help
History (29)
The cholesterol metabolite 25-hydroxycholesterol restrains the transcriptional regulator SREBP2 and limits intestinal IgA plasma cell differentiation.
Hiccupping and regurgitation via the drain tube of the ProSeal laryngeal mask.
Bass, David
Development of a screening tool to identify patients with axial spondyloarthritis: a cognitive interview study.
Benefits and harms of roflumilast in moderate to severe COPD.
See All 29 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Benefits and harms of roflumilast in moderate to severe COPD.
Yu T, Fain K, Boyd CM, Singh S, Weiss CO, Li T, Varadhan R, Puhan MA. Benefits and harms of roflumilast in moderate to severe COPD. Thorax. 2014 Jul; 69(7):616-22.
View in:
PubMed
subject areas
Aged
Aminopyridines
Benzamides
Cyclopropanes
Female
Humans
Male
Middle Aged
Phosphodiesterase 4 Inhibitors
Placebos
Pulmonary Disease, Chronic Obstructive
Risk Assessment
authors with profiles
Sonal Singh MD, MPH